Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ERYTECH Pharma S.A (PA: ERYP)

 
ERYP Technical Analysis
5
As on 9th Jun 2023 ERYP STOCK Price closed @ 0.83 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.22 & Strong Sell for SHORT-TERM with Stoploss of 1.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ERYPSTOCK Price

Open 0.83 Change Price %
High 0.84 1 Day -0.01 -1.19
Low 0.83 1 Week -0.05 -5.68
Close 0.83 1 Month 0.01 1.22
Volume 49858 1 Year -1.29 -60.85
52 Week High 2.14 | 52 Week Low 0.34
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
ERYP
Daily Charts		 ERYP
Intraday Charts		 Whats New @
Bazaartrend		 ERYP
Free Analysis
 
ERYP Important Levels Intraday
RESISTANCE0.85
RESISTANCE0.84
RESISTANCE0.84
RESISTANCE0.84
SUPPORT0.82
SUPPORT0.82
SUPPORT0.82
SUPPORT0.81
 
ERYP Forecast April 2024
Share
4th UP Forecast2.22
3rd UP Forecast1.77
2nd UP Forecast1.5
1st UP Forecast1.22
1st DOWN Forecast0.44
2nd DOWN Forecast0.16
3rd DOWN Forecast-0.11
4th DOWN Forecast-0.56
 
ERYP Weekly Forecast
4th UP Forecast1.06
3rd UP Forecast0.99
2nd UP Forecast0.94
1st UP Forecast0.90
1st DOWN Forecast0.76
2nd DOWN Forecast0.72
3rd DOWN Forecast0.67
4th DOWN Forecast0.60
 
ERYP Forecast2024
4th UP Forecast4.65
3rd UP Forecast3.42
2nd UP Forecast2.67
1st UP Forecast1.91
1st DOWN Forecast-0.25
2nd DOWN Forecast-1.01
3rd DOWN Forecast-1.76
4th DOWN Forecast-2.99
 
 
ERYP Other Details
Segment EQ
Market Capital 72873808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ERYP Address
ERYP
 
ERYP Latest News
 
Your Comments and Response on ERYTECH Pharma S.A
 
ERYP Business Profile
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine-dependent cancers. It has research collaborations with the Fox Chase Cancer Center to advance the preclinical development of erymethionase for the treatment of homocystinuria; and Queen's University of Canada to advance the preclinical development of eryminase for the treatment of arginase-1-deficiency. The company was incorporated in 2004 and is headquartered in Lyon, France. Address: 60 Avenue Rockefeller, Lyon, France, 69008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service